Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin versus sitagliptin add-on to metformin for 72-hour glycemic profile assessment in type 2 diabetes
2009-018117-40Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Galvus + metformin with Januvia + metformin (2 arms). Primary endpoint: MAGE after 8 weeks. Started Feb 2010; status: completed.
02
Drugs
vildagliptinsitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-018117-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018117-40.